Connection

Majdi Al-Hasan to Humans

Back to Details
This is a "connection" page, showing publications Majdi Al-Hasan has written about Humans.
Majdi Al-Hasan
Connection Strength
0.996
Humans
  1. Temporal Association between Influenza Vaccination Coverage and Ambulatory Antibiotic Use in Children. Pediatr Infect Dis J. 2022 07 01; 41(7):600-602.
    View in: PubMed
    Score: 0.032
  2. Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection. Infection. 2022 Aug; 50(4):873-877.
    View in: PubMed
    Score: 0.031
  3. Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2022 02; 84(2):131-135.
    View in: PubMed
    Score: 0.030
  4. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
    View in: PubMed
    Score: 0.030
  5. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
    View in: PubMed
    Score: 0.028
  6. Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients? Drugs Aging. 2020 09; 37(9):627-633.
    View in: PubMed
    Score: 0.028
  7. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
    View in: PubMed
    Score: 0.027
  8. Resilience of the Pitt Bacteremia Score: 3 Decades and Counting. Clin Infect Dis. 2020 04 15; 70(9):1834-1836.
    View in: PubMed
    Score: 0.027
  9. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
    View in: PubMed
    Score: 0.027
  10. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132.
    View in: PubMed
    Score: 0.026
  11. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
    View in: PubMed
    Score: 0.026
  12. COPD Exacerbations - A Target for Antibiotic Stewardship. N Engl J Med. 2019 07 11; 381(2):174-175.
    View in: PubMed
    Score: 0.026
  13. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289.
    View in: PubMed
    Score: 0.026
  14. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clin Microbiol Infect. 2020 Mar; 26(3):299-306.
    View in: PubMed
    Score: 0.026
  15. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria? Clin Infect Dis. 2019 04 08; 68(8):1431.
    View in: PubMed
    Score: 0.025
  16. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.025
  17. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019 Aug; 47(4):571-578.
    View in: PubMed
    Score: 0.025
  18. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
    View in: PubMed
    Score: 0.024
  19. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
    View in: PubMed
    Score: 0.024
  20. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
    View in: PubMed
    Score: 0.023
  21. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
    View in: PubMed
    Score: 0.023
  22. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.023
  23. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.022
  24. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.022
  25. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.022
  26. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.021
  27. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.021
  28. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.021
  29. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
    View in: PubMed
    Score: 0.021
  30. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.021
  31. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
    View in: PubMed
    Score: 0.019
  32. Bloodstream infections and central line-associated bloodstream infections. Surg Clin North Am. 2014 Dec; 94(6):1233-44.
    View in: PubMed
    Score: 0.019
  33. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscesses. Am J Med Sci. 2013 Oct; 346(4):341-4.
    View in: PubMed
    Score: 0.017
  34. Impact of Gram-negative bloodstream infection on long-term allograft survival after kidney transplantation. Transplantation. 2011 Jun 15; 91(11):1206-10.
    View in: PubMed
    Score: 0.015
  35. Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60.
    View in: PubMed
    Score: 0.014
  36. Recurrent gram-negative bloodstream infection: a 10-year population-based cohort study. J Infect. 2010 Jul; 61(1):28-33.
    View in: PubMed
    Score: 0.014
  37. Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010 Feb; 85(2):139-44.
    View in: PubMed
    Score: 0.013
  38. Bacteremia complicating gram-negative urinary tract infections: a population-based study. J Infect. 2010 Apr; 60(4):278-85.
    View in: PubMed
    Score: 0.013
  39. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009 Jul; 64(1):169-74.
    View in: PubMed
    Score: 0.013
  40. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother. 2009 Apr; 53(4):1386-94.
    View in: PubMed
    Score: 0.012
  41. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008 Aug; 121(8):702-8.
    View in: PubMed
    Score: 0.012
  42. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007 Oct; 128(4):622-7.
    View in: PubMed
    Score: 0.011
  43. Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation. Pharmacotherapy. 2023 01; 43(1):85-95.
    View in: PubMed
    Score: 0.008
  44. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey. World J Emerg Surg. 2022 03 17; 17(1):17.
    View in: PubMed
    Score: 0.008
  45. A pandemic recap: lessons we have learned. World J Emerg Surg. 2021 09 10; 16(1):46.
    View in: PubMed
    Score: 0.007
  46. Novel method of calculating adjusted antibiotic use by microbiological burden. Infect Control Hosp Epidemiol. 2021 06; 42(6):688-693.
    View in: PubMed
    Score: 0.007
  47. Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 04; 42(4):503-505.
    View in: PubMed
    Score: 0.007
  48. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
    View in: PubMed
    Score: 0.007
  49. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey. World J Emerg Surg. 2017; 12:34.
    View in: PubMed
    Score: 0.006
  50. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346.
    View in: PubMed
    Score: 0.005
  51. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016; 11:33.
    View in: PubMed
    Score: 0.005
  52. Comparison of ?-lactam plus aminoglycoside versus ?-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017 Feb; 29(1):30-37.
    View in: PubMed
    Score: 0.005
  53. Temporal trends, clinical characteristics, and outcomes of histoplasmosis in a tertiary care center in Kentucky, 2000 to 2009. J Int Assoc Provid AIDS Care. 2014 Mar-Apr; 13(2):100-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.